Agile Therapeutics Management
Management criteria checks 3/4
Agile Therapeutics' CEO is Al Altomari, appointed in Oct 2010, has a tenure of 12.75 years. total yearly compensation is $840.79K, comprised of 71.4% salary and 28.6% bonuses, including company stock and options. directly owns 0.044% of the company’s shares, worth €3.54K. The average tenure of the management team and the board of directors is 2.9 years and 5 years respectively.
Key information
Al Altomari
Chief executive officer
US$840.8k
Total compensation
| CEO salary percentage | 71.4% |
| CEO tenure | 12.8yrs |
| CEO ownership | 0.04% |
| Management average tenure | 2.9yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$841k | US$601k | -US$25m |
| Sep 30 2022 | n/a | n/a | -US$62m |
| Jun 30 2022 | n/a | n/a | -US$59m |
| Mar 31 2022 | n/a | n/a | -US$64m |
| Dec 31 2021 | US$2m | US$594k | -US$71m |
| Sep 30 2021 | n/a | n/a | -US$69m |
| Jun 30 2021 | n/a | n/a | -US$68m |
| Mar 31 2021 | n/a | n/a | -US$61m |
| Dec 31 2020 | US$2m | US$555k | -US$52m |
| Sep 30 2020 | n/a | n/a | -US$40m |
| Jun 30 2020 | n/a | n/a | -US$29m |
| Mar 31 2020 | n/a | n/a | -US$22m |
| Dec 31 2019 | US$1m | US$507k | -US$19m |
| Sep 30 2019 | n/a | n/a | -US$16m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$18m |
| Dec 31 2018 | US$2m | US$494k | -US$20m |
| Sep 30 2018 | n/a | n/a | -US$22m |
| Jun 30 2018 | n/a | n/a | -US$26m |
| Mar 31 2018 | n/a | n/a | -US$28m |
| Dec 31 2017 | US$1m | US$492k | -US$28m |
| Sep 30 2017 | n/a | n/a | -US$27m |
| Jun 30 2017 | n/a | n/a | -US$28m |
| Mar 31 2017 | n/a | n/a | -US$29m |
| Dec 31 2016 | US$1m | US$472k | -US$29m |
Compensation vs Market: Al's total compensation ($USD840.79K) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Al's compensation has been consistent with company performance over the past year.
CEO
Al Altomari (64 yo)
12.8yrs
Tenure
US$840,792
Compensation
Mr. Alfred F. Altomari, also known as Al, had been an Independent Chairman of the Board of Baudax Bio Inc. since November 2019 until May 04, 2022. He has been the Chief Executive Officer at Agile Therapeut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 12.8yrs | US$840.79k | 0.044% $ 3.5k | |
| Senior VP & Chief Administrative Officer | less than a year | US$544.38k | 0.0014% $ 110.5 | |
| Senior VP & Chief Medical Officer | 2.9yrs | US$545.86k | 0% $ 0 | |
| Principal Financial Officer | 1.2yrs | no data | no data | |
| Head of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior VP and Chief Corporate Planning & Supply Chain Officer | 5.8yrs | US$557.49k | 0.00099% $ 79.8 | |
| Consultant | 9.5yrs | US$964.04k | no data | |
| Senior VP & Chief Commercial Officer | 1.5yrs | no data | no data | |
| Controller | no data | no data | no data |
2.9yrs
Average Tenure
57yo
Average Age
Experienced Management: 0AL's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 19.4yrs | US$840.79k | 0.044% $ 3.5k | |
| Independent Director | 8.7yrs | US$66.63k | 0.00096% $ 77.4 | |
| Lead Independent Director | 7yrs | US$96.63k | 0.00096% $ 77.4 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Board Observer | no data | no data | no data | |
| Independent Director | 3.1yrs | US$56.63k | 0.00089% $ 71.8 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 1.8yrs | US$56.63k | 0.00044% $ 35.5 | |
| Independent Director | 3.1yrs | US$71.63k | 0.00072% $ 58.1 |
5.0yrs
Average Tenure
67yo
Average Age
Experienced Board: 0AL's board of directors are considered experienced (5 years average tenure).